[REGN] YoY Quarter Result on 31-Mar-2013 [#Q1]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
03-May-2013
Financial Year
2013
Quarter
31-Mar-2013 [#Q1]
Profit Trend
QoQ- -78.98%
YoY- 748.63%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Revenue 1,200,849 869,612 625,740 439,664 231,789 112,204 103,534 50.39%
PBT 330,151 276,523 175,263 141,831 11,651 -43,663 -30,304 -
Tax 164,415 200,502 109,820 42,957 -610 -216 218 201.40%
NP 165,736 76,021 65,443 98,874 11,651 -43,447 -30,522 -
Tax Rate -49.80% -72.51% -62.66% -30.29% 5.24% - - -
Total Cost 1,035,113 793,591 560,297 340,790 220,138 155,651 134,056 40.54%
Ratio Analysis
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
NP Margin 13.80 8.74 10.46 22.49 5.03 -38.72 -29.48 -
Per Share
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
EPS 1.74 0.74 0.69 1.02 0.12 -0.49 -0.38 -
EPS Diluted 1.59 0.66 0.61 0.90 0.11 -0.49 -0.38 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.